Apellis Pharmaceuticals EBIT (TTM) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

20.00 -0.53 (-2.58%) USD | NASDAQ | Jan 16, 15:54

View EBIT (TTM) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBIT (TTM) Chart

Start Trial

View Historical Data

Start Trial

View EBIT Definition

Start Trial

EBIT is an acronym for earnings before interest and taxes.

View EBIT (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EBIT (TTM) Benchmarks

Start Trial

Biogen, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade
Fortress Biotech, Inc.	Upgrade
Ultragenyx Pharmaceutical, Inc.	Upgrade
Fulcrum Therapeutics, Inc.	Upgrade